Pharvaris N.V.
NasdaqGS:PHVS
$ 31,60
+ $0,01 (0,03%)
31,60 $
+$0,01 (0,03%)
End-of-day quote: 06/09/2026

Competitors

Companies Market Cap G R O W T H
Takeda Pharmaceutical Company
TSE:4502
7.859,69 B 10,31% 2/5 15,97% -12,21% 20,60% DOWN
CSL
ASX:CSL
48,28 B 9,75% 4/6 -9,99% 70,20% 40,60% DOWN
Ionis Pharmaceuticals
NasdaqGS:IONS
12,33 B 2,00% 1/6 -7,08% -187,31% 40,79% UP
BioMarin Pharmaceutical
NasdaqGS:BMRN
11,19 B 12,22% 5/6 39,07% 59,63% 47,64% DOWN
BioCryst Pharmaceuticals
NasdaqGS:BCRX
2,12 B 103,27% 5/6 -10,27% 35,13% 128,09% UP
Intellia Therapeutics
NasdaqGM:NTLA
1,80 B -7,72% 1/6 -9,22% 22,29% 70,67% UP
KalVista Pharmaceuticals
NasdaqGM:KALV
1,44 B 0,00% 1/5 0,00% 0,00% 0,04% UP
×